Table 2 Clinical data of ovarian cancer patients
Characteristics | Study group (N = 48) (n, %) |
|---|---|
Histological type | |
Papillary Serous cystadenocarcinoma | 27 (56.25%) |
Mucinous cystadenocarcinoma | 15 (31.25%) |
Endometrioid carcinoma | 4 (8.33%) |
Clear cell carcinoma | 2 (4.16%) |
Grading | |
G1 | 6 (12.5%) |
G2 | 28 (58.33%) |
G3 | 14 (29.16%) |
FIGO stage | |
I | 9 (18.75%) |
II | 5 (10.41%) |
III | 15 (31.25%) |
IV | 19 (39.58%) |